# AXTLE
> **NDA210661** · New Drug Application · Sponsor: AVYXA HOLDINGS · Approved 2024-06-28
## Drug
- **FDA Application Number:** NDA210661
- **Application type:** New Drug Application
- **Brand name:** AXTLE
- **Generic name:** PEMETREXED
- **Active ingredients:** PEMETREXED DIPOTASSIUM
- **Dosage form:** POWDER
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** AVYXA HOLDINGS
- **Manufacturer:** Avyxa Pharma, LLC
- **First approval:** 2024-06-28
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210661)
---
*AI Analytics · CC0 1.0*